Clinical trials
Terminated Central Nervous System Diseases trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Xenon Pharmaceuticals Inc. | 2 |
| Remedy Pharmaceuticals, Inc. | 1 |
| Shire | 1 |
| University Hospital of Mont-Godinne | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Diseases | 7 |
| Central Nervous System Diseases | 7 |
| Nervous System Diseases | 6 |
| Alzheimer Disease | 2 |
| Dementia | 2 |
| Disease | 2 |
| Epilepsy | 2 |
| Epileptic Syndromes | 2 |
| Mental Disorders | 2 |
| Neurocognitive Disorders | 2 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.